PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with PTSD (Post-Traumatic Stress Disorder)
- People who have been taking the same psychiatric medications at a stable dose for at least 4 weeks
Who may not be able to join:
- People whose bipolar disorder is currently unstable or not well-managed
- People who are currently experiencing psychosis (such as hallucinations or delusions)
- People who are currently having thoughts of suicide or harming others, with a plan or intention to act on those thoughts
- People who are currently struggling with severe substance use that requires urgent medical care
- People who are currently receiving another type of therapy that focuses specifically on trauma
- People with significant memory or thinking difficulties that would make it hard to participate in assessments and therapy sessions (for example, advanced dementia or severe brain injury)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elizabeth Alpert, PhD, National Center for PTSD at VA Boston Healthcare System, BU School of Medicine, Psychiatry
Phone: 857-364-6190
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient-provider communication: VR-CoDES (Posttreatment); PTSD: CAPS-5 (Posttreatment); PTSD: CAPS-5 (Follow-up); Feasibility assessed by CPT adherence; Feasibility assessed by CPT competence; Feasibility assessed by PE adherence; Feasibility assessed by PE competence; Acceptability: Client satisfaction (Mid-treatment); Acceptability: Client satisfaction (Posttreatment); Acceptability: Therapeutic Alliance (Mid-treatment); Acceptability: Therapeutic Alliance (Posttreatment); Treatment Completion
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.